(Q36952002)

17 August 2017

1 reference

title

Anticonvulsant hypersensitivity syndrome: implications for pharmaceutical care (English)

1 reference

Anticonvulsant hypersensitivity syndrome

17 August 2017

main subject

1 reference

KarenBeth H Bohan

1

1 reference

17 August 2017

Tarannum F Mansuri

series ordinal

2

1 reference

17 August 2017

Natalie M Wilson

series ordinal

3

1 reference

17 August 2017

language of work or name

English

0 references

publication date

1 October 2007

1 reference

17 August 2017

1 reference

17 August 2017

volume

27

1 reference

17 August 2017

issue

10

1 reference

17 August 2017

page(s)

1425-1439

1 reference

Anticonvulsant hypersensitivity syndrome: a review

17 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.10.1425

Anticonvulsant hypersensitivity syndrome: incidence, prevention and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.10.1425

Anticonvulsant hypersensitivity syndrome associated with reactivation of cytomegalovirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.10.1425

Carbamazepine-induced hypersensitivity syndrome associated with transient hypogammaglobulinaemia and reactivation of human herpesvirus 6 infection demonstrated by real-time quantitative polymerase chain reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.10.1425

Different patterns of cytokines, ECP and immunoglobulin profiles at two adverse drug reactions in a patient.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.10.1425

Hypersensitivity syndrome due to 2 anticonvulsant drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.10.1425

Human herpesvirus 6 encephalitis associated with hypersensitivity syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.10.1425

Drug-induced hypersensitivity syndrome due to carbamazepine associated with reactivation of human herpesvirus 7.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.10.1425

Association between anticonvulsant hypersensitivity syndrome and human herpesvirus 6 reactivation and hypogammaglobulinemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.10.1425

Case reports and literature review: the association between reactivation of human herpes virus-6 and peripheral white blood cell count in patients with carbamazepine-induced hypersensitivity syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.10.1425

Carbamazepine-induced hypersensitivity syndrome, associated with human herpesvirus 6 reactivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.10.1425

Medical genetics: a marker for Stevens-Johnson syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.10.1425

Current understanding of delayed anticonvulsant hypersensitivity reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.10.1425

Anticonvulsant hypersensitivity syndrome. In vitro assessment of risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.10.1425

Familial occurrence of hypersensitivity to phenytoin

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.10.1425

Risk of serious cutaneous disorders after initiation of use of phenytoin, carbamazepine, or sodium valproate: a record linkage study

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.10.1425

Severe case of phenytoin-induced anticonvulsant hypersensitivity syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.10.1425

Anticonvulsant hypersensitivity syndrome: lymphocyte toxicity assay for the confirmation of diagnosis and risk assessment

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.10.1425

Phenytoin hypersensitivity syndrome masquerading as fever and systemic illness of unknown origin in an HIV-infected patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.10.1425

Lamotrigine-associated anticonvulsant hypersensitivity syndrome in bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.10.1425

Drug-induced hypersensitivity syndrome due to anticonvulsants in a two-year-old boy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.10.1425

Anticonvulsant hypersensitivity syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.10.1425

Spectrum of anticonvulsant hypersensitivity syndrome: controversy of treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.10.1425

Anticonvulsant hypersensitivity syndrome: treatment with corticosteroids and intravenous immunoglobulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.10.1425

Possible atypical cross-sensitivity between phenytoin and carbamazepine in the anticonvulsant hypersensitivity syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.10.1425

Anticonvulsant hypersensitivity syndrome from addition of lamotrigine to divalproex

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.10.1425

Valproic Acid and hypersensitivity syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.10.1425

The anticonvulsant hypersensitivity syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.10.1425

A novel lymphocyte toxicity assay to assess drug hypersensitivity syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.10.1425

Association of anticonvulsant hypersensitivity syndrome with Herpesvirus 6, 7.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.10.1425

Human herpesvirus 6 infection associated with anticonvulsant hypersensitivity syndrome and reactive haemophagocytic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.10.1425

The usefulness of skin tests to prove drug hypersensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.10.1425

Characterization of the microsomal epoxide hydrolase gene in patients with anticonvulsant adverse drug reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.10.1425

21 January 2018

Identifiers

DOI

10.1592/PHCO.27.10.1425

1 reference

17 August 2017

1 reference